亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Factors of effective neovascularization after surgical treatment of moyamoya disease

烟雾病 血运重建 医学 吻合 内科学 灌注 心脏病学 外科 疾病 侧支循环 搭桥手术 动脉 心肌梗塞
作者
В А Лукшин,Anna Shulgina,D Yu Usachev
出处
期刊:Zhurnal voprosy neĭrokhirurgii imeni N. N. Burdenko [Izdatelstvo Meditsina]
卷期号:87 (3): 29-29 被引量:1
标识
DOI:10.17116/neiro20238703129
摘要

Background. Moyamoya disease is a chronic cerebrovascular disease with complex pathophysiology. This disease is characterized by unique and unclear features of neoangiogenesis in natural course of disease and after surgical treatment. Natural collateral circulation was discussed in the first part of the article. Objective. To analyze the nature and degree of neoangiogenesis after combined revascularization in patients with moyamoya disease and to identify the factors of effective direct and indirect components. Material and methods. We analyzed 80 patients with moyamoya disease who underwent 134 surgical interventions. The main group consisted of patients after combined revascularization (79 operations), two control groups comprised patients after indirect (19) and direct (36) operations. We assessed postoperative MR data, function of each component of revascularization considering angiographic and perfusion modes and their contribution to the overall result of revascularization. Results. Factors of effective direct components of revascularization are large diameter of acceptor (p=0.028) and donor (p<0.0001) arteries, as well as double anastomoses (p=0.009). Factors of effective indirect synangiosis are younger age of patients (p=0.009), «ivy» symptom (p=0.005), enlargement of M4 branches of the MCA (p=0.026), transdural (p=0.004) and leptomeningeal (p=0.001) collaterals, use of more indirect components (p=0.027). Combined surgery provides the best angiographic (p=0.023) and perfusion (p<0.0001) results of revascularization. If one of the components is ineffective, other one ensures favorable result of surgery. Conclusion. Combined revascularization is preferable in patients with moyamoya disease. However, a differentiated approach involving the effectiveness of various components of revascularization should be taken into account when planning surgical tactics. Understanding the state of collateral circulation in patients with moyamoya disease both in natural course of disease and after surgical treatment opens the ways for their rational use.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小马甲应助机器猫nzy采纳,获得10
2秒前
所所应助机器猫nzy采纳,获得10
2秒前
共享精神应助机器猫nzy采纳,获得10
2秒前
慕青应助机器猫nzy采纳,获得10
2秒前
英俊的铭应助机器猫nzy采纳,获得10
2秒前
SamuelLiu完成签到,获得积分10
2秒前
Ava应助机器猫nzy采纳,获得10
2秒前
小蘑菇应助机器猫nzy采纳,获得10
2秒前
小蘑菇应助机器猫nzy采纳,获得10
2秒前
JamesPei应助机器猫nzy采纳,获得10
2秒前
Hello应助机器猫nzy采纳,获得10
3秒前
SamuelLiu发布了新的文献求助10
5秒前
隐形曼青应助机器猫nzy采纳,获得10
14秒前
orixero应助机器猫nzy采纳,获得10
14秒前
万能图书馆应助机器猫nzy采纳,获得10
14秒前
华仔应助机器猫nzy采纳,获得10
14秒前
英俊的铭应助机器猫nzy采纳,获得10
15秒前
星辰大海应助机器猫nzy采纳,获得10
15秒前
科研通AI6.4应助机器猫nzy采纳,获得50
15秒前
DW应助机器猫nzy采纳,获得10
15秒前
上官若男应助机器猫nzy采纳,获得10
15秒前
丘比特应助机器猫nzy采纳,获得10
15秒前
2589完成签到,获得积分10
20秒前
ding应助初景采纳,获得100
20秒前
远方完成签到,获得积分10
21秒前
GJ完成签到 ,获得积分10
26秒前
顾矜应助铁甲小宝采纳,获得10
26秒前
落后电脑完成签到,获得积分10
28秒前
懵懂的念波完成签到,获得积分10
30秒前
37秒前
shaylee完成签到 ,获得积分10
41秒前
铁甲小宝发布了新的文献求助10
45秒前
LELE完成签到 ,获得积分0
46秒前
共享精神应助Andrew采纳,获得10
47秒前
52秒前
56秒前
皮戾完成签到,获得积分10
56秒前
初景发布了新的文献求助100
57秒前
欣慰小夏完成签到,获得积分10
59秒前
万能图书馆应助皮戾采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Principles of town planning: translating concepts to applications 1000
Navigating Normative Orders. Interdisciplinary Perspectives 800
1 Peter and Christ's Descent to the Dead in Its Early Christian Reception 700
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7738617
求助须知:如何正确求助?哪些是违规求助? 9287702
关于积分的说明 20184570
捐赠科研通 7316575
什么是DOI,文献DOI怎么找? 3305931
关于科研通互助平台的介绍 2458288
邀请新用户注册赠送积分活动 2315849